The prolyl-4-hydroxylase domain (PHD) enzymes are regarded as the molecular oxygen sensors. There is an interplay between oxygen availability and cellular metabolism, which in turn has significant effects on the functionality of innate immune cells, such as macrophages. However, if and how PHD enzymes affect macrophage metabolism are enigmatic. We hypothesized that macrophage metabolism and function can be controlled via manipulation of PHD2. We characterized the metabolic phenotypes of PHD2-deficient RAW cells and primary PHD2 knockout bone marrow-derived macrophages (BMDM). Both showed typical features of anaerobic glycolysis, which were paralleled by increased pyruvate dehydrogenase kinase 1 (PDK1) protein levels and a decreased pyruvate dehydrogenase enzyme activity. Metabolic alterations were associated with an impaired cellular functionality. Inhibition of PDK1 or knockout of hypoxia-inducible factor 1␣ (HIF-1␣) reversed the metabolic phenotype and impaired the functionality of the PHD2-deficient RAW cells and BMDM. Taking these results together, we identified a critical role of PHD2 for a reversible glycolytic reprogramming in macrophages with a direct impact on their function. We suggest that PHD2 serves as an adjustable switch to control macrophage behavior.
M
acrophages are an essential component of innate immunity and are well recognized to play critical roles in inflammation, tumor progression, and tissue repair, for example, after an ischemic insult (1) . Under aerobic conditions, the oxidative breakdown of pyruvate within the mitochondria is the prevalent source of energy in most cells. Upon a decrease in oxygen availability, cells shift the metabolism toward anaerobic glycolysis. In line with this, macrophages can use aerobic or anaerobic glycolysis for energy production, depending on the context. There is a growing understanding that macrophage function can be altered by cellular metabolism (2) . One of the key factors in switching aerobic to anaerobic metabolism at the transcriptional level is the hypoxia-inducible factor (HIF). HIF comprises two subunits: the constitutively regulated HIF␤ subunit and one of three oxygen-regulated HIF␣ subunits (HIF-1␣, HIF-2␣, or HIF-3␣) (3) . The protein stability of HIF␣ is regulated by the three prolyl-4-hydroxylase domain (PHD) enzymes, PHD1, -2, and -3, which hydroxylate HIF␣ in an oxygen-dependent manner (for a review, see references 4 and 5). The hydroxylated product is recognized by the pVHL protein, which results in ubiquitination and proteasomal degradation of the ␣-subunit. In hypoxia, the hydroxylation and degra-dation are inhibited, and thus HIF␣ is stabilized, which finally results in HIF-dependent transcriptional activation of a repertoire of target genes. Besides many others, genes encoding glycolytic enzymes and pyruvate dehydrogenase kinase 1 (PDK1) belong to the target genes (6, 7) . Both determine the glycolytic cellular program. PHD enzymes are of interest for the ongoing development of small-molecule inhibitors which will allow stimulation of HIF-dependent gene expression in normoxia (8) .
PHD1 to -3 have common but also nonredundant functions (9) . In the case of innate immunity, the role of PHD3 has been analyzed in detail (10) (11) (12) . The role of PHD2, however, is less well understood. In particular, if and how PHD2 affects macrophage metabolism have not been described before. We therefore analyzed the consequences related to cell metabolism and function for PHD2 knockouts in bone marrow-derived macrophages (BMDM) isolated from LysMCre ϩ/Ϫ ϫ Phd2 flox/flox mice (PHD2 conditional knockout [PHD2 cKO] mice) and in the monocyte/macrophage cell line RAW264.
RESULTS
PHD2-deficient macrophages induce a hypoxic gene expression pattern in normoxia, including that of PDK1, a central regulator of pyruvate dehydrogenase (PDH). BMDM isolated from PHD2 flox/flox ϫ LysMCre mice (PHD2 cKO) and RAW cells transfected with a constitutively active short hairpin RNA (shRNA) targeting PHD2 (shPHD2 cells) showed an 80% reduction of PHD2 RNA, with a consequential increase of PHD3 RNA expression, compared to that in wild-type (wt) BMDM and wt RAW cells (Fig. 1A) . The compensatory increase of the HIF-1 target PHD3 is in line with other cell/tissue-specific PHD2 knockout mouse models (13) . Besides PHD3, other metabolismrelated HIF gene targets, such as the Glut-1, PFK1, PDK1, COX4-2, LonP, and BNIP3 genes, were upregulated. The gene expression patterns for the PHD2 cKO and shPHD2 cells resembled the pattern of HIF target genes in wt BMDM and wt RAW cells after incubation under hypoxic conditions. Quantitatively, however, the levels of the HIF target genes were lower in the shPHD2 and PHD2 cKO cells in normoxia than in the respective wt cells in hypoxia, which indicates that the reduction of PHD2 induced a partial HIF response, possibly due to the fact that the other PHDs, i.e., PHD1 and PHD3, were still active. This assumption was further supported by the fact that after hypoxic incubation of shPHD2 and PHD2 cKO cells the RNA levels of the HIF target genes were further increased, to an extent similar to that in the respective wt cells in hypoxia. Levels of cell viability/cell death, as determined by the number of annexin V (AV) singlepositive cells, were not different in untreated wt BMDM and wt RAW cells compared to PHD2 cKO and shPHD2 cells, respectively, or after treatment with 1 mM dimethyloxalylglycine (DMOG) (Fig. 1B) .
PHD2 protein levels were likewise decreased in PHD2 cKO and shPHD2 cells (Fig. 1C) . Whereas HIF-1␣ and HIF-2␣ were detectable in BMDM isolated from wt mice in hypoxia only, PHD2 cKO BMDM revealed high HIF-1␣ and HIF-2␣ protein levels in normoxia. In the RAW cells, HIF-2␣ was not detectable with the antibodies applied. For HIF-1␣, a pattern similar to that in the BMDM was observed. Comparable to the HIF target RNA expression levels, HIF-1␣ and HIF-2␣ protein levels were further increased after exposure of the PHD2 cKO cells and shPHD2 RAW cells to hypoxia. Taken together, these data demonstrate a biologically relevant reduction of PHD2, with subsequent stabilization of the HIF␣ proteins and induction of HIF target genes, such as PDK1, in a cell line model and in genetically modified primary macrophages partially mimicking hypoxia. The increased expression of PDK1 was further analyzed at the protein level. PDK1 is a major regulator in central metabolic pathways, including glucose consumption pathways. It acts in part by regulating the activity of the pyruvate dehydrogenase (PDH) by phosphorylation, which results in inactivation of the enzyme. PDH is one part of a mitochondrial multienzyme complex that catalyzes the oxidative decarboxylation of pyruvate and is one of the major enzymes responsible for the regulation of homeostasis of carbohydrate fuels in mammals. The induction of PDK1 in PHD2-deficient cells in normoxia was also detectable at the protein level (Fig. 1D ). In line with this, PDH was found to be more phosphorylated in the shPHD2 RAW cells and the PHD2 cKO BMDM than in their wild-type counterparts. In hypoxia, both wt and PHD2-deficient cells showed increased PDK1 protein levels and phosphorylation of PDH. In parallel, we determined the PDH activity in cell extracts isolated from wt cells and PHD2-deficient cells after exposure to normoxic or hypoxic conditions (Fig. 1E) . shPHD2 cells exhibited a significantly lower PDH activity in normoxia, which was also observed in wt cells after treatment with the PHD inhibitor DMOG. In hypoxia, a decreased PDH activity was observed in wt and shPHD2 cells, still with significantly lower levels in the knockdown cells. Since PDK1 is a critical regulator of cellular metabolism, we next analyzed the glycolytic capacity of the PHD2-deficient cells.
PHD2-deficient macrophages show a switch to glycolytic metabolism. The utilization of glycolysis to meet energy demands can be characterized by the oxygen consumption rate (OCR) and the extracellular acidification rate (ECAR) after stimulation. The basal oxygen consumption rate and maximal respiration after uncoupling of the mitochondria by use of carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) were significantly decreased in the PHD2-deficient cells or after treating wt cells with DMOG, which indicates that as a consequence of inhibiting PHD activity, macrophages shift their source of energy to anaerobic glycolysis ( Fig. 2A and B) . This was further supported by a significantly increased glycolytic function as determined by the extracellular acidification rate after glucose or oligomycin treatment, which reflects basal glycolysis or the overall glycolytic capacity, respectively (Fig. 2C to F) . In line with this, we found increased lactate levels in the supernatants of shPHD2 RAW cells and PHD2 cKO BMDM compared to those in the supernatants of their respective wt cells (Fig. 2G) . Lactate levels were likewise increased after DMOG treatment or exposure of the cells to hypoxic conditions. Incubating wt and PHD2 cKO BMDM without glucose at 20% O 2 abolished lactate production, demonstrating that the glucose in the culture medium was indeed the major source of lactate production (Fig. 2H) .
A fully operative cellular metabolism of macrophages is important to provide the necessary amount of ATP. Aerobic and anaerobic glycolysis pathways differ in the net production of ATP. In line with the less efficient anaerobic glycolysis pathway, levels of ATP were significantly diminished in the PHD2 cKO BMDM and the shPHD2 RAW cells as well as after treating wt RAW cells with DMOG or exposing them to hypoxic conditions ( Fig. 3A) , which might affect their functionality, namely, polarization, migration, and phagocytosis. Macrophages display remarkable plasticity and can change their phenotype upon stimulation (14) . The most prominent macrophage populations are the M1-and M2-polarized macrophages. To analyze if the metabolic alterations in the PHD2-deficient cells affected macrophage polarization, we analyzed RNA levels for the M1 markers tumor necrosis factor alpha (TNF-␣), inducible nitric oxide synthase (iNOS), and macrophage chemoattractant protein 1 (MCP-1) as well as the M2 markers Ym1 and Fizz in wt and PHD2 cKO BMDM. Arginase, which is also an M2 marker, was not detectable in nonstimulated wt BMDM. None of the M1 or M2 markers were changed in the PHD2 cKO BMDM (Fig. 3B ). Subsequently, we stimulated the cells with lipopolysaccharide (LPS) and the Th1 cytokine gamma interferon (IFN-␥) or with the Th2 cytokine interleukin-4 (IL-4) to functionally characterize M1 and M2 polarization (Fig.  3C ). Successful M1 and M2 polarization after stimulation was verified by increased RNA levels for TNF-␣, iNOS, and MCP-1 after treatment with LPS as well as those for Ym1, arginase, and Fizz after treatment with IL-4. Expression levels of the M1 and M2 marker RNAs were not different between wild-type and PHD2 cKO BMDM. A lack of macrophage polarization in the PHD2 cKO BMDM was additionally confirmed by a nonbiased RNA microarray gene expression assay (see Tables S1 and S2 in the supplemental material). In total, 42 genes were found to be upregulated significantly in PHD2 cKO BMDM, including the PHD3, BNIP3, PFK1, and PDK1 genes, and 56 were found to be downregulated significantly. Pathway analysis of the RNAs identified to be up-or downregulated in the PHD2 cKO BMDM versus wt BMDM did not reveal any indications of macrophage polarization. Likewise, treatment of wt or PHD2 cKO BMDM with DMOG resulted in altered RNA expression but no clear pattern of M1-or M2-associated genes (Fig. 3D ). Whereas DMOG resulted in significantly decreased RNA levels for TNF-␣ and MCP-1, those for iNOS, Fizz, and arginase were significantly increased in wt as well as cKO BMDM. Taken collectively, the metabolic alterations in response to DMOG treat- RAW cells, wt BMDM, and PHD2 cKO cells were incubated at 20% O 2 or 1% O 2 for 24 h, and subsequently, intracellular ATP levels were determined (n ϭ 6 independent samples per condition). (Right) wt RAW cells were incubated with 1 mM DMOG for the indicated times, and ATP levels were then determined (n ϭ 6 or 7 independent samples per condition). (B and C) RNA levels for M1 and M2 markers in resting wt BMDM and cKO cells (B) or after stimulation with IL-4 (20 nM) or LPS (100 ng/ml) and IFN-␥ (20 nM) for 24 h (C). Numbers of copies of the respective RNAs were quantified relative to the number of RNA copies of the housekeeping gene mS12. (D) RNA levels for M1 and M2 markers in resting wt BMDM and PHD2 cKO cells were analyzed after treatment of the cells with 1 mM DMOG for 24 h. Fold changes of the RNA levels for the indicated genes in DMOG-treated wt or cKO BMDM were determined by comparison to the levels in the nontreated cells (n ϭ 3 to 6 independent samples per condition). Data are means and SEM. *, P Ͻ 0.05. ber and in single-cell migration experiments. Significantly fewer PHD2 cKO BMDM and shPHD2 RAW cells than their respective wt cells migrated in the Boyden chamber (Fig.  4A) . Additionally, the accumulated distances in single-cell migration experiments were found to be reduced (Fig. 4B) . The impaired migration capacity of the PHD2-deficient RAW cells could be mimicked by treating wt RAW cells with the PHD inhibitor DMOG or exposing them to hypoxic conditions (Fig. 4C) . In line with the migration deficit, the phagocytosis capacity was disturbed in the shPHD2 RAW cells and the PHD2 cKO BMDM (Fig. 4D) . Comparable to the migration capacity, the decreased phagocytosis could be mimicked in wt RAW cells by incubating the cells under hypoxic conditions or by treatment with DMOG.
Differential migration was not due to modulated chemokine receptor expression, since quantifying CCR2, CCR4, CCR5, CCR7, and CXCR4 RNA levels by reverse transcription-PCR (RT-PCR) after exposure of wild-type and PHD2 cKO BMDM to 20% O 2 or 1% O 2 did not reveal any difference between the cell types besides an upregulation of CCR1 in the PHD2 cKO cells (Fig. 4E) . However, we observed a significant upregulation of CCR1 and CCR5 and a slight upregulation of CXCR4 in hypoxia, which is in line with the literature (15, 16) . Since the migration deficit was not due to a striking differential expression of chemokine receptors, we further analyzed the impacts of the metabolic alterations on the migratory and phagocytosis capacities.
Regulation of PDH activity by PDK is critical for macrophage function. To obtain insight into the importance of altered PDK1 levels and PDH activity for the functional impairment of the PHD2-deficient macrophages, we treated cells with the PDK inhibitor dichloroacetate (DCA). DCA binds to PDK1 near the helix bundle in the N-terminal part of the protein. Bound DCA promotes local conformational changes that are communicated to both nucleotide-binding and lipoyl-binding pockets of PDK1, leading to the inactivation of kinase activity (17) . DCA treatment reestablished the decreased PDH activity in the shPHD2 RAW cells (Fig. 5A ). In line with this, shPHD2 cells and PHD2 cKO BMDM produced less lactate and demonstrated significantly increased ATP levels after DCA treatment (Fig. 5B and C) . Reversal of the metabolic reprogramming after DCA treatment was also observed by analyzing the ECAR. Whereas the nontreated shPHD2 cells and PHD2 cKO BMDM had significantly increased glycolysis and glycolytic capacity, these were significantly decreased in the DCA-treated cells (Fig. 5D ). Finally, we tested if DCA treatment was able to normalize the migration and phagocytosis deficits ( Fig. 5E and F) . Most interestingly, DCA treatment was indeed able to increase the impaired migration and phagocytosis capacities of the shPHD2 RAW and PHD2 cKO cells, to levels comparable to those of the wild-type cells, strongly indicating that the metabolic programming via PDK1 per se was responsible for the functional alterations observed as a consequence of downregulating PHD2 expression.
PDK1 has been described as a HIF target gene (7) . In a previous report, we demonstrated that HIF-1␣ in PHD3 cKO BMDM is not stabilized in normoxia (12) , which is in sharp contrast to the effect seen in the PHD2 cKO BMDM described here. This was further supported by the fact that HIF target genes, including the PDK1 gene, were not significantly increased in PHD3 cKO BMDM, in contrast to PHD2 cKO and wt BMDM in normoxia and hypoxia, respectively (Fig. 6A) . The genes identified in the gene array analysis (PHD2 cKO versus wt BMDM) were additionally compared to PHD3-regulated genes described earlier (12) . Most interestingly, just 13 genes were found to be regulated in the PHD2 cKO as well as the PHD3 cKO BMDM, indicating PHD isoformspecific effects (Table S3 ). In line with this, ATP and lactate levels as well as the accumulated migration distance were not altered in PHD3 cKO versus wt BMDM (Fig.  6B) . To further analyze if PHD2 mediates its effects via HIF-1␣, we generated double cKO (dcKO) mice (PHD2 flox/flox ϫ HIF-1␣ flox/flox ϫ LysMcre ϩ/Ϫ mice). dcKO BMDM had a blunted response in RNA levels for the HIF target genes encoding PHD3, Glut-1, PFK1, PDK1, Cox4.2, and LonP in hypoxia (Fig. 7A) . The metabolic phenotypes of the PHD2 cKO BMDM, i.e., decreased ATP levels, increased lactate levels, decreased OCR, and decreased migration, were rescued as a consequence of the HIF-1␣ knockout, demon- strating that HIF-1 and PDK1 are the two main mediators of the PHD2-induced metabolic alterations (Fig. 7B to D) .
DISCUSSION
Macrophages are critical effector cells for innate immunity but also for adaptive immune function, by recruiting further cells to the inflamed tissue (18) . To fulfill their functions, macrophages need to migrate efficiently into the affected tissue and phagocytose invading pathogens or cell debris. Both characteristic features were severely impaired in the PHD2-deficient RAW cell model as well as the primary BMDM used in our study. Impaired migration is in line with two previous studies analyzing the migratory capacity of PHD2-deficient peritoneal macrophages as well as shPHD2 RAW cells toward MCP-1 as a stimulus (19, 20) . Infiltrating inflammatory cells, including macrophages, play an important role in tissue remodeling after an insult. In line with this, LysMCre PHD2 flox/flox animals showed less macrophage infiltration in the aorta during hypertensive cardiovascular remodeling (19) . This was associated with protection from hypertension-induced left ventricular hypertrophy and reduced ejection fraction. The basis for impaired macrophage migration, however, has not been analyzed in more depth so far.
The functionality of macrophages is significantly affected by their polarization as well as their metabolic phenotype. Macrophages can generally be classified into two major groups, i.e., M1 (classically activated) and M2 (alternatively activated) macrophages (21) . Both subgroups have specific functions in the inflammatory clearance of pathogens and in tissue repair (22) . HIF-1␣ and HIF-2␣ are known to affect macrophage polarization, with predominant roles of HIF-1␣ for M1 macrophages and HIF-2␣ for M2 macrophages (23) . Since the PHD enzymes regulate HIF␣ stability, it is tempting to speculate that inhibition of their enzymatic activity will also affect macrophage polarization. Characterization of resting as well as stimulated wt and PHD2 cKO macrophages, however, did not reveal any striking pattern which would indicate a clear polarization. It is important that this observation does not contrast with a study by Takeda et al. in which M2 polarization as a consequence of PHD2 knockout was described (24) . They observed M2 polarization in heterozygous but not homozygous PHD2-deficient macrophages, which matches our observations with homozygous PHD2-deficient macrophages.
In stark contrast to the unaltered polarization, we found an influence of PHD2 on reprogramming of mitochondrial metabolism. This effect was mediated via PHD2-dependent regulation of PDK1 expression. This is in accordance with a recent report showing that PHD2 can regulate PDK1 in livers/hepatocytes (25) . In line with higher levels of PDK1 and more phosphorylation of its target, PDH, the basal and stimulated oxygen consumption rates were significantly lower in the PHD2-deficient cells, accompanied by an increased glycolytic capacity. PDK1 is a key regulatory enzyme in glucose metabolism. The PDH complex, which is regulated by PDK1, converts pyruvate produced from the glycolytic flux to acetyl coenzyme A (acetyl-CoA). Pyruvate-derived acetyl-CoA then enters the tricarboxylic acid (TCA) cycle, which generates the NADH that fuels the electron transport chain for oxidative phosphorylation. In hypoxia, PDH activity is inhibited via PDK1-mediated phosphorylation, which induces anaerobic glucose metabolic homeostasis under conditions of limited oxygen availability. This mechanism is widely used by tumor cells and is part of the so-called Warburg effect. Warburg described that unlike most normal tissues, cancer cells tend to "ferment" glucose into lactate even in the presence of sufficient oxygen to support mitochondrial oxidative phosphorylation (26) . In the case of immune cells, however, the metabolic adaptation is part of their physiological response. Innate immune cells, such as neutrophils, likewise depend on anaerobic glycolysis for ATP production, which is also suggested by the fact that they harbor only a few mitochondria (27) . In contrast, macrophages have numbers of mitochondria comparable to those in other body cells, and thus have a higher metabolic flexibility, which allows a quick metabolic switch from aerobic to anaerobic glycolysis. The hallmarks of anaerobic glycolysis are reduced ATP production, increased lactate levels, and decreased oxygen consumption (28) . All three features were significantly altered in the PHD2-deficient macrophages, indicating an anaerobic metabolic shift. Neutrophils and monocytes/macrophages fulfill their physiological function in severely hypoxic areas, such as those with inflammation or ischemia. Unlike short-lived neutrophils, macrophages survive longer in the body, up to 
FIG 6
No metabolic phenotype in PHD3-deficient macrophages. (A) wt BMDM and PHD3 cKO macrophages were incubated for 24 h at 20% or 1% O 2 . RNA levels for the indicated genes were analyzed by qRT-PCR. RNA levels in wt BMDM were set to 1. Fold changes of the RNA levels for the indicated genes in PHD3 cKO BMDM or wt cells in hypoxia were determined by comparison to the levels in the wt cells in normoxia (n ϭ 3 independent samples per condition). (B) ATP (n ϭ 5 independent samples) and lactate (n ϭ 4 independent samples) levels as well as accumulated migration distances were determined for wt BMDM and PHD3 cKO macrophages.
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Molecular and Cellular Biology a maximum of several months. Compared to that in the oxygenated blood, the partial O 2 pressure (pO 2 ) in most tissues is significantly lower. Thus, compared to monocytes, macrophages need to be able to adapt to the hypoxic conditions which reflect their physiological environment. In contrast, short-lived neutrophils enter inflamed hypoxic tissue, where they die quickly to fulfill their function. This is also reflected by the fact that in contrast to other cells, they die upon exposure to hypoxia. Most interestingly, the metabolic phenotypes observed for the shPHD2 RAW cells and cKO BMDM mimicked the effects seen in wt cells in hypoxia. The metabolic adaptations thus might ensure function and viability of the cells as long as possible under hypoxic conditions. A lower migration rate as a consequence helps to keep the cells in place until they are stimulated during the course of acute inflammation. Recent evidence suggests an intricate link between metabolism and macrophage activation (29) . Thus, it becomes important to know what kind of metabolic changes occur after immune cell activation and if the altered metabolism per se can serve as a controller of the immunomodulatory functionality. Analyzing metabolic aspects as a consequence of blocking PHD2 thus might answer the question of what changes in the regulation of energy metabolism are necessary for macrophages and if these can be targeted to control innate immune function. In this regard, our data clearly indicate that deleting PHD2 in macrophages is sufficient to drive an anaerobic glycolytic phenotype in normoxia and interferes with migration and phagocytosis. PHD enzyme activity can be inhibited by use of competitive oxoglutarate analogues. Respective inhibitors are being developed to specifically interfere with the PHD/HIF signaling pathway (30) . Short-term treatment of wt macrophages with the PHD inhibitor DMOG or exposure of the cells to hypoxia was indeed sufficient to mimic the metabolic features of the genetically modified macrophages. Moreover, the metabolic switch in the PHD2-deficient macrophages was readily reversible by inhibition of PDK1, demonstrating that PHD2-mediated metabolic changes are not decretory. DCA treatment rescued all hallmarks of anaerobic glycolysis in the PHD2-deficient cells, including the impaired functionality. A critical role of PDK1 in macrophage metabolism and function has been described earlier and is in line with our findings (31) . Via alteration of PDK1 activity, the cellular ATP levels as well as extracellular lactate levels are modulated. ATP as well as a lactate-enriched environment has been demonstrated to add to immunomodulatory functions by altering the migratory activity of defense cells (32, 33) . The use of PDK1 as a molecule to target deregulated energy metabolism is an emerging strategy for cancer therapy (34) . Redirection of glucose metabolism from glycolysis to oxidation, which reverses the Warburg effect, leads to inhibition of proliferation and induction of caspase-mediated apoptosis in tumor cells. Thus far, DCA is the most extensively studied PDK1 inhibitor; however, it has limited use for therapeutic purposes because of its low potency and high toxicity. PHD inhibitors, on the other hand, have entered preclinical models and clinical trials, so interfering with PHD2 activity might serve as a better strategy to influence immune functions via metabolic reprogramming (35) .
Taken collectively, the data in our study show that while PHD2 is not required for macrophage polarization, it controls macrophage metabolism and function. Mechanistically, the balance between aerobic and anaerobic glycolysis is affected by PHD2 via the expression and activity of PDK1. This adds to our understanding of the functionality of macrophages in normoxia and hypoxia. In addition, our findings might point to the possibility to specifically interfere with the inflammatory function of macrophages by inhibiting PHD2 activity.
MATERIALS AND METHODS
Chemicals. The oxoglutarate analogue dimethyloxalylglycine (DMOG; Enzo Life Sciences, Lörrach, Germany) and the PDK inhibitor dichloroacetate (DCA; Sigma) were used at final concentrations of 1 mM and 5 mM, respectively. LPS (Enzo Life Sciences, Lörrach, Germany), IFN-␥, and IL-4 (Peprotech, Hamburg, Germany) were applied at concentrations of 100 ng/ml, 20 nM, and 20 nM, respectively, or as indicated.
Myeloid lineage-specific conditional knockout mice. All animals in this study were backcrossed to C57BL/6 mice at least five times. Phd2 flox/flox ϫ LysMcre ϩ/Ϫ mice were crossed with Phd2 flox/flox mice to obtain PHD2 cKO mice (Phd2 flox/flox ϫ LysMcre ϩ/Ϫ ) and littermate control wild-type mice (Phd2 flox/flox ). Generation of Phd3 flox/flox ϫ LysMcre ϩ/Ϫ (PHD3 cKO) mice was described previously (12) . To obtain PHD2/HIF-1␣ double-knockout macrophages, Phd2 flox/flox ϫ LysMcre ϩ/Ϫ mice were crossed with Hif-1␣ flox/flox mice (B6.129-Hif1atm3Rsjo/J; Jackson Laboratories) to obtain PHD2 flox/flox ϫ HIF-1␣ flox/flox ϫ LysMcre ϩ/Ϫ mice (dcKO mice). All animal work conformed to institutional guidelines and was approved by the Niedersächsische Landesamt für Verbraucherschutz und Lebensmittelsicherheit (approval number 33.9-42502-04-11/0413).
Isolation and differentiation of BMDM. Bone marrow cells were isolated from the femur. After 24 h of cell culture, nonadherent monocytes were harvested and seeded in Pluznik's medium (Dulbecco's modified Eagle's medium [DMEM] supplemented with 0.2 mM L-glutamine, 0.1 mM sodium pyruvate, 50 U/ml penicillin G, 50 g/ml streptomycin, 10% heat-inactivated fetal calf serum [FCS] , 5% heatinactivated horse serum [Pan Biotech, Aidenbach, Germany], 0.05% 1:1,000-diluted ␤-mercaptoethanol [Carl Roth GmbH, Karlsruhe, Germany], and 15% L929 cell-conditioned medium [36] ) and then allowed to differentiate for 7 days. Adherent bone marrow-derived macrophages (BMDM) were detached with 3.5 ml Accutase (PAA Laboratories, Cölbe, Germany) and resuspended in culture medium (DMEM supplemented with 0.2 mM L-glutamine, 0.1 mM sodium pyruvate, 1 mM HEPES, 50 U/ml penicillin G, 50 g/ml streptomycin, and 10% heat-inactivated fetal calf serum). For analysis of lactate production without addition of glucose, glucose-free medium (Pan Biotech) was used as indicated. Successful differentiation analysis, 2.5 ϫ 10 4 RAW cells or 4.0 ϫ 10 4 BMDM were seeded per well. The medium was replaced with XF assay medium supplemented with 4.5 g/liter glucose and 1 mM sodium pyruvate and incubated without CO 2 for 30 min. After measuring basal respiration, the oxygen consumption was analyzed after sequential addition of 1.5 M oligomycin, 1 M FCCP, 2 M rotenone, and 1 M antimycin A.
For ECAR determination, 2.5 ϫ 10 4 RAW cells or 8 ϫ 10 4 BMDM were seeded per well. Cells were washed with XF Glycostress medium (D5030 DMEM, 134 mM NaCl, 3 mg phenol red, 2 mM L-glutamine, pH 7.35). The cells were incubated for 15 min at 37°C without CO 2 . ECAR was analyzed after sequential addition of 10 mM glucose, 1.5 to 3 M oligomycin, and 100 mM 2-deoxyglucose (2-DG).
Statistical analyses. Statistical analyses were performed using Student's two-tailed t test. Data shown are means Ϯ standard errors of the means (SEM). P values of Ͻ0.05 were considered statistically significant.
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